Patent details
EP3471780
Title:
TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
Basic Information
- Publication number:
- EP3471780
- PCT Application Number:
- US2017038003
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178142238
- PCT Publication Number:
- WO2017218974
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
- French Title of Invention:
- TRAITEMENT DE LA DMLA À L'AIDE D'UN VARIANT D'AAV2 ET D'AFLIBERCEPT
- German Title of Invention:
- BEHANDLUNG VON AMD MIT AAV2-VARIANTE MIT AFLIBERCEPT
- SPC Number:
-
Dates
- Filing date:
- 16/06/2017
- Grant date:
- 28/10/2020
- EP Publication Date:
- 24/04/2019
- PCT Publication Date:
- 21/12/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/10/2020
- EP B1 Publication Date:
- 28/10/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 16/06/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/10/2020
-
-
- Name:
- Adverum Biotechnologies, Inc.
- Address:
- 1035 O'Brien Drive Suite A, Menlo Park, California 94025, United States (US)
Agent
- Name:
- NOVAGRAAF BREVETS
- From:
- 30/12/2020
- Address:
- BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
- To:
Inventor
1
- Name:
- GASMI, Mehdi
- Address:
- United States (US)
2
- Name:
- BLUMENKRANZ, Mark
- Address:
- United States (US)
Priority
- Priority Number:
- 201662351234 P
- Priority Date:
- 16/06/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 48/00;
A61P 27/02;
C12N 15/09;
A61K 35/761;
Publication
European Patent Bulletin
- Issue number:
- 202044
- Publication date:
- 28/10/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/06/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 19/06/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- DENNEMEYER & CO